Cargando…

Determination of Anti-Adeno-Associated Virus Vector Neutralizing Antibody Titer with an In Vitro Reporter System

Adeno-associated virus (AAV) vectors are a platform of choice for in vivo gene transfer applications. However, neutralizing antibodies (NAb) to AAV can be found in humans and some animal species as a result of exposure to the wild-type virus, and high-titer NAb develop following AAV vector administr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meliani, Amine, Leborgne, Christian, Triffault, Sabrina, Jeanson-Leh, Laurence, Veron, Philippe, Mingozzi, Federico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc. 2015
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403012/ https://www.ncbi.nlm.nih.gov/pubmed/25819687 http://dx.doi.org/10.1089/hgtb.2015.037

Ejemplares similares

Capsid-specific removal of circulating antibodies to adeno-associated virus vectors
por: Bertin, Berangere, et al.
Publicado: (2020)

Determination of Anti-Adeno-Associated Viral Vector Neutralizing Antibodies in Patients With Heart Failure in the Cardiovascular Foundation of Colombia (ANVIAS): Study Protocol
por: Rincon, Melvin Y, et al.
Publicado: (2016)

Adeno-Associated Viral Vectors at the Frontier between Tolerance and Immunity
por: Mingozzi, Federico, et al.
Publicado: (2015)

Production and Titering of Recombinant Adeno-associated Viral Vectors
por: McClure, Christina, et al.
Publicado: (2011)

Human Immune Responses to Adeno-Associated Virus (AAV) Vectors
por: Ronzitti, Giuseppe, et al.
Publicado: (2020)

Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction
por: Fitzpatrick, Zachary, et al.
Publicado: (2018)

Emerging Immunogenicity and Genotoxicity Considerations of Adeno-Associated Virus Vector Gene Therapy for Hemophilia
por: Monahan, Paul E., et al.
Publicado: (2021)

Fast HPLC-based affinity method to determine capsid titer and full/empty ratio of adeno-associated viral vectors
por: Heckel, Jakob, et al.
Publicado: (2023)

Modifiers of Adeno-Associated Virus-Mediated Gene Expression in Implication for Serotype-Universal Neutralizing Antibody Assay
por: Krotova, Karina, et al.
Publicado: (2020)

Autophagy determines efficiency of liver‐directed gene therapy with adeno‐associated viral vectors
por: Hösel, Marianna, et al.
Publicado: (2017)

Bat adeno-associated viruses as gene therapy vectors with the potential to evade human neutralizing antibodies
por: Li, Ya, et al.
Publicado: (2019)

Rapid determination of SARS-CoV-2 antibody neutralization titer using Bio-Rad Bio-Plex correlates strongly with pseudovirus-determined neutralization titer
por: Heaps, Amy L., et al.
Publicado: (2023)

Adeno‐associated virus‐vectored influenza vaccine elicits neutralizing and Fcγ receptor‐activating antibodies
por: Demminger, Daniel E, et al.
Publicado: (2020)

Towards a piRNA prediction using multiple kernel fusion and support vector machine
por: Brayet, Jocelyn, et al.
Publicado: (2014)

In utero intracerebroventricular delivery of adeno-associated viral vectors to target mouse choroid plexus and cerebrospinal fluid
por: Jang, Ahram, et al.
Publicado: (2022)

Higher Seroprevalence of Anti-Adeno-Associated Viral Vector Neutralizing Antibodies Among Racial Minorities in the United States
por: Khatri, Arpana, et al.
Publicado: (2022)

Multiplex PCR-Based Neutralization (MPBN) Assay for Titers Determination of the Three Types of Anti-Poliovirus Neutralizing-Antibodies
por: Manukyan, Hasmik, et al.
Publicado: (2020)

Complement Activation by Adeno-Associated Virus-Neutralizing Antibody Complexes
por: West, Cara, et al.
Publicado: (2023)

Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration
por: Meliani, Amine, et al.
Publicado: (2018)

Exclusive labeling of direct and indirect pathway neurons in the mouse neostriatum by an adeno-associated virus vector with Cre/lox system
por: Okamoto, Shinichiro, et al.
Publicado: (2020)

A scalable method for the production of high-titer and high-quality adeno-associated type 9 vectors using the HSV platform
por: Adamson-Small, Laura, et al.
Publicado: (2016)

Prediction of Adeno-Associated Virus Neutralizing Antibody Activity for Clinical Application
por: Wang, Mei, et al.
Publicado: (2015)

Anti-feline panleukopenia virus serum neutralizing antibody titer in domestic cats with the negative or low hemagglutination inhibition antibody titer
por: SOMA, Takehisa, et al.
Publicado: (2018)

Confirmatory detection of neutralizing antibodies to AAV gene therapy using a cell-based transduction inhibition assay
por: Kasprzyk, Theresa, et al.
Publicado: (2022)

Pre-existing humoral immunity and complement pathway contribute to immunogenicity of adeno-associated virus (AAV) vector in human blood
por: Smith, Corinne J., et al.
Publicado: (2022)

A translationally optimized AAV-UGT1A1 vector drives safe and long-lasting correction of Crigler-Najjar syndrome
por: Ronzitti, Giuseppe, et al.
Publicado: (2016)

Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition
por: Gilbert, Peter B., et al.
Publicado: (2022)

The seroprevalence of neutralizing antibodies against the adeno-associated virus capsids in Japanese hemophiliacs
por: Kashiwakura, Yuji, et al.
Publicado: (2022)

Induction of Hematopoietic Microchimerism by Gene-Modified BMT Elicits Antigen-Specific B and T Cell Unresponsiveness toward Gene Therapy Products
por: Martinet, Jérémie, et al.
Publicado: (2016)

Short-lived recombinant adeno-associated virus transgene expression in dystrophic muscle is associated with oxidative damage to transgene mRNA
por: Dupont, Jean-Baptiste, et al.
Publicado: (2015)

Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler–Najjar Syndrome
por: Aronson, Sem J., et al.
Publicado: (2019)

Engineered adeno-associated virus 3 vector with reduced reactivity to serum antibodies
por: Ito, Mika, et al.
Publicado: (2021)

Adeno-associated virus receptor complexes and implications for adeno-associated virus immune neutralization
por: Large, Edward E., et al.
Publicado: (2023)

AdenoBuilder: A platform for the modular assembly of recombinant adenoviruses
por: Jang, Yumi, et al.
Publicado: (2022)

A Quantitative In Vitro Potency Assay for Adeno-Associated Virus Vectors Encoding for the UGT1A1 Transgene
por: Aronson, Sem J., et al.
Publicado: (2020)

A recombinant bovine herpesvirus-4 vectored vaccine delivered via intranasal nebulization elicits viral neutralizing antibody titers in cattle
por: Williams, Laura B. A., et al.
Publicado: (2019)

Pre-existing antibodies to candidate gene therapy vectors (adeno-associated vector serotypes) in domestic cats
por: Li, Pengfei, et al.
Publicado: (2019)

Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults
por: Miyaji, Karina Takesaki, et al.
Publicado: (2017)

High neutralizing antibody titer in intensive care unit patients with COVID-19
por: Liu, Li, et al.
Publicado: (2020)

Factors influencing neutralizing antibody titers elicited by coronavirus disease 2019 vaccines
por: Kung, Yu-An, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ml4c7h39104pl7s8ji1aa4bmdu